The present review discusses hepatocyte sources for a bioartificial liver. Intended requirements for cell sources are for example: synthesis of plasma proteins, detoxification and regulation. The need for highly differentiated hepatocytes is stressed. Furthermore, the gap between this objective on the one hand and the real possibilities as they appear today on the other is shown. Alternatives to primarily isolated hepatocytes are discussed, thereby elucidating the limits of established cell lines. In summary, it is postulated that the results expected from a bioartificial liver, are closely related to the source and type of cells used.
CastellJ.V., Gomez-LechonM.J., DavidM., FabraR., TrullenqueR., HeinrichP.C.. Acute-phase response of human hepatocytes. Regulation of acute phase protein synthesis by interleukin-6.Hepatology1990; 12: 1179–86.
2.
HammerC.. Transgenic pigs as potential organ donors.Diatra Journal1994; 4: 29–32.
3.
MichalopulosG.. HGF and liver regeneration.Gastroenterol Jpn1993; 28: 36–9.
4.
MichalopulosG., HouckK.A., DolanM.L., LuettekeN.C.. Control of hepatocyte replication by two serum factors.Cancer Research1984; 44: 4414–9.
5.
MichalopulosG., PitotH.C.. Primary culture of parenchymal liver cells on collagen membranes.Experimental Cell Research1975; 94: 70–8.
6.
GislasonG., LobdellD., KellyJ., SussmannN.. A treatment system for implementing an extracorporeal liver assist device.Artif Organs1994; 18: 385–9.
7.
SussmanN., KellyJ.. Improved liver function following treatment with an extracorporeal liver assist device.Artif Organs1993; 17: 27–9.
8.
JavittN.. HepG2 cells as a resource for metabolic studies; lipoprotein, cholesterol, and bile acids.FASEB J1990; 4: 161–8.
9.
StevensonD., LinH., TongM., MarshallG.. Characteristics of a cell line (TONG/HCC) established from a human hepatocellular carcinoma.Hepatology1987; 7: 1291–5.
10.
StraussM., HeringS., LieberA., HerrmannG., GriffinB.E., ArnoldW.. Stimulation of cell division and fibroblast focus formation by antisense repression of retinoblastoma protein synthesis.Oncogene, (in press) 1995.
11.
SchuetzE.G., SchuetzJ.D., StromS.C.. Regulation of human liver cytochromes p-450 in family 3A in primary and continuous culture of human hepatocytes.Hepatology1993; 18: 1254–62.
12.
StangeJ., MitznerS., StraussM.. Comparison of encapsulated primary isolated and established hepatocytes for their applicability as liver replacement.Artif Organs1993; 17: 488.
13.
MullerT.E., JaurequiH.O.. Letter to the editor.Artif Organs1993; 17: 44–5.
14.
SussmanN., KellyJ.. Letter to the editor.Artif Organs1993; 17: 43–4.
15.
HeringS., GriffinB.E., StraussM.. Immortalization of human fetal sinusoidal liver cells by polyoma virus large T antigen.Experimental Cell Research1991; 195: 1–7.
16.
GerlachJ., BrombacherJ., KlöppelK., SchnoyN., NeuhausP.. Comparison of four methods for mass hepatocyte isolation from pig and human livers.Transplantation1994; 57: 1318–22.
17.
JaureguiH.O., GannK.L.. Mammalian hepatocytes as a foundation for treatment in human liver failure.Journal of Cellular Biochemistry1991; 45: 359–65.
18.
JaureguiH.O., NaikS., DriscollJ.L., SolomonB.A., GalettiP.M.. Adult rat hepatocyte cultures as the cellular component of an artificial hybrid liver. In: PaulJ.P., GaylorJ.D.S., CourtneyJ.M., GilchristT., eds. Strathclyde Bioengineering Seminars: Biomaterials in Artificial Organs.Macmillan, 1983; 130–9.
StangeJ., MitznerS., RamlowW., GliescheT., HicksteinH., SchmidtR.. A new procedure for the removal of protein bound drugs and toxins.ASAIO Journal1993; 39: 621–5.
21.
StangeJ., RamlowW., MitznerS., SchmidtR., KlinkmannH.. Dialysis against a recycled albumin solution enables the removal of albumin bound toxins.Artif Organs1993; 17: 809–13.
22.
BuchnerN.L.. Liver regeneration: an overview.Journal of Gastroenterology and Hepatology1991; 6: 615–24.
23.
EmersonT.E.J., FournelM.A., LeachW.J., RedensT.B.. Protection against disseminated intravascular coagulaton and death by antithrombin-lll in the escherichia coli endotoxemic rat.Circulatory Shock1987; 21: 1–13.
24.
RedensT.B., LeachW.J., BogdanoffD.A., EmersonJ.T.E.. Synergistic protection from lung damage by combining antithrombin-lll and alpha1-proteinase inhibitor in the E. coli endotoxemic sheep pulmonary dysfunction model.Circulatory Shock1988; 26: 15–26.
25.
SussmanN., KellyJ.. Letter to the editor.Artif Organs1993; 17: 43–4.
